My Quote Request
No products added yet
6505-01-385-0787
20 Products
OPTIRAY 350
IOVERSOL INJECTION
NSN, MFG P/N
6505013850787
NSN
6505-01-385-0787
MFG
MALLINCKRODT DIAGNOSTICS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 74.000 PERCENTAGE W/V IVEROSOL
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PROVIDES 35% (350 MG/ML) ORGANICALLY BOUND IODINE
Related Searches:
NDC00206-8455-25
PIPERACILLIN SODIUM
NSN, MFG P/N
6505013849024
NSN
6505-01-384-9024
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 4 GRAMS PIPERACILLIN EQUIVALENT AND 500 MG TAZOBACTAM EQUIVALENT ACTIVE INGREDIENTS; 10 VIALS PER PG; THERAPEUTICALLY EQUIVALENT TO ZOSYN BY LEDERLE; USE: ANTIBIOTIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN SODIUM AND TAZOBACTAM FOR INJECTION VIAL 10S
Related Searches:
ZOSYN
PIPERACILLIN SODIUM
NSN, MFG P/N
6505013849024
NSN
6505-01-384-9024
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 4 GRAMS PIPERACILLIN EQUIVALENT AND 500 MG TAZOBACTAM EQUIVALENT ACTIVE INGREDIENTS; 10 VIALS PER PG; THERAPEUTICALLY EQUIVALENT TO ZOSYN BY LEDERLE; USE: ANTIBIOTIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN SODIUM AND TAZOBACTAM FOR INJECTION VIAL 10S
Related Searches:
NDC00019-1333-16
IOVERSOL INJECTION
NSN, MFG P/N
6505013849148
NSN
6505-01-384-9148
MFG
MALLINCKRODT DIAGNOSTICS
Description
PRIMARY CONTAINER CONTENT QUANTITY: 150.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 74% PERCENT IOVERSOL ACTIVE INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
3011
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849244
NSN
6505-01-384-9244
3011
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849244
NSN
6505-01-384-9244
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 104.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 2.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 1.000 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 109.500 MILLIEQUIVALENTS CHLORIDE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 3.78 L (1 GAL); 4 BOTTLES PER CASE; NON-PYROGENIC; THIS ACID CONCENTRATE IS FORMULATED TO BE USED IN A THREE STREAM HEMODIALYSIS MACHINE CALIBRATED TO AN ACID CONCENTRATE DILUTION RATIO OF 1:34; MUST BE USED IN CONJUNCTION WITH FRESENIUS FB-3-XXX SODIUM
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: BICARBONATE CONCENTRATE
~1: PER LITER AND 3.000 MILLIEQUIVALENTS ACETIC ACID PER LITER AND 2.000 GRAMS DEXTROSE PER LITER
Related Searches:
FC-3011
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849244
NSN
6505-01-384-9244
FC-3011
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849244
NSN
6505-01-384-9244
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 104.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 2.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 1.000 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 109.500 MILLIEQUIVALENTS CHLORIDE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 3.78 L (1 GAL); 4 BOTTLES PER CASE; NON-PYROGENIC; THIS ACID CONCENTRATE IS FORMULATED TO BE USED IN A THREE STREAM HEMODIALYSIS MACHINE CALIBRATED TO AN ACID CONCENTRATE DILUTION RATIO OF 1:34; MUST BE USED IN CONJUNCTION WITH FRESENIUS FB-3-XXX SODIUM
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: BICARBONATE CONCENTRATE
~1: PER LITER AND 3.000 MILLIEQUIVALENTS ACETIC ACID PER LITER AND 2.000 GRAMS DEXTROSE PER LITER
Related Searches:
LIQUIFLO
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849244
NSN
6505-01-384-9244
LIQUIFLO
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849244
NSN
6505-01-384-9244
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 104.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 2.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 1.000 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 109.500 MILLIEQUIVALENTS CHLORIDE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 3.78 L (1 GAL); 4 BOTTLES PER CASE; NON-PYROGENIC; THIS ACID CONCENTRATE IS FORMULATED TO BE USED IN A THREE STREAM HEMODIALYSIS MACHINE CALIBRATED TO AN ACID CONCENTRATE DILUTION RATIO OF 1:34; MUST BE USED IN CONJUNCTION WITH FRESENIUS FB-3-XXX SODIUM
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: BICARBONATE CONCENTRATE
~1: PER LITER AND 3.000 MILLIEQUIVALENTS ACETIC ACID PER LITER AND 2.000 GRAMS DEXTROSE PER LITER
Related Searches:
OFC-3011
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849244
NSN
6505-01-384-9244
OFC-3011
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849244
NSN
6505-01-384-9244
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 104.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 2.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 1.000 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 109.500 MILLIEQUIVALENTS CHLORIDE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 3.78 L (1 GAL); 4 BOTTLES PER CASE; NON-PYROGENIC; THIS ACID CONCENTRATE IS FORMULATED TO BE USED IN A THREE STREAM HEMODIALYSIS MACHINE CALIBRATED TO AN ACID CONCENTRATE DILUTION RATIO OF 1:34; MUST BE USED IN CONJUNCTION WITH FRESENIUS FB-3-XXX SODIUM
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: BICARBONATE CONCENTRATE
~1: PER LITER AND 3.000 MILLIEQUIVALENTS ACETIC ACID PER LITER AND 2.000 GRAMS DEXTROSE PER LITER
Related Searches:
3017
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849254
NSN
6505-01-384-9254
3017
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849254
NSN
6505-01-384-9254
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 103.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 1.000 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 106.500 MILLIEQUIVALENTS CHLORIDE PER LITER AND 3.000 MILLIEQUIVALENTS ACETIC ACID PER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NON-PYROGENIC; 3.78 L (1 GAL); 4 BOTTLES PER CASE; THIS ACID CONCENTRATE IS FORMULATED TO BE USED IN A THREE STREAM HEMODIALYSIS MACHINE CALIBRATED TO AN ACID CONCENTRATE DILUTION RATIO OF 1:34; IT MUST BE USED IN CONJUNCTION WITH FRESENIUS FB-3-XXX
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: LITER AND 2.000 GRAMS DEXTROSE PER LITER
~1: SODIUM BICARBONATE CONCENTRATE
Related Searches:
FC-3017
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849254
NSN
6505-01-384-9254
FC-3017
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849254
NSN
6505-01-384-9254
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 103.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 1.000 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 106.500 MILLIEQUIVALENTS CHLORIDE PER LITER AND 3.000 MILLIEQUIVALENTS ACETIC ACID PER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NON-PYROGENIC; 3.78 L (1 GAL); 4 BOTTLES PER CASE; THIS ACID CONCENTRATE IS FORMULATED TO BE USED IN A THREE STREAM HEMODIALYSIS MACHINE CALIBRATED TO AN ACID CONCENTRATE DILUTION RATIO OF 1:34; IT MUST BE USED IN CONJUNCTION WITH FRESENIUS FB-3-XXX
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: LITER AND 2.000 GRAMS DEXTROSE PER LITER
~1: SODIUM BICARBONATE CONCENTRATE
Related Searches:
LIQUIFLO
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849254
NSN
6505-01-384-9254
LIQUIFLO
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849254
NSN
6505-01-384-9254
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 103.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 1.000 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 106.500 MILLIEQUIVALENTS CHLORIDE PER LITER AND 3.000 MILLIEQUIVALENTS ACETIC ACID PER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NON-PYROGENIC; 3.78 L (1 GAL); 4 BOTTLES PER CASE; THIS ACID CONCENTRATE IS FORMULATED TO BE USED IN A THREE STREAM HEMODIALYSIS MACHINE CALIBRATED TO AN ACID CONCENTRATE DILUTION RATIO OF 1:34; IT MUST BE USED IN CONJUNCTION WITH FRESENIUS FB-3-XXX
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: LITER AND 2.000 GRAMS DEXTROSE PER LITER
~1: SODIUM BICARBONATE CONCENTRATE
Related Searches:
OFC-3017
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849254
NSN
6505-01-384-9254
OFC-3017
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013849254
NSN
6505-01-384-9254
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 103.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 1.000 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 106.500 MILLIEQUIVALENTS CHLORIDE PER LITER AND 3.000 MILLIEQUIVALENTS ACETIC ACID PER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NON-PYROGENIC; 3.78 L (1 GAL); 4 BOTTLES PER CASE; THIS ACID CONCENTRATE IS FORMULATED TO BE USED IN A THREE STREAM HEMODIALYSIS MACHINE CALIBRATED TO AN ACID CONCENTRATE DILUTION RATIO OF 1:34; IT MUST BE USED IN CONJUNCTION WITH FRESENIUS FB-3-XXX
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: LITER AND 2.000 GRAMS DEXTROSE PER LITER
~1: SODIUM BICARBONATE CONCENTRATE
Related Searches:
OLB-3-01
SODIUM BICARBONATE SOLUTION
NSN, MFG P/N
6505013849288
NSN
6505-01-384-9288
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 84.000 GRAMS SODIUM BICARBONATE PER LITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONCENTRATE; NON-PYROGENIC; THIS BICARBONATE CONCENTRATE IS FORMULATED TO BE USED IN A THREE STREAM HEMODIALYSIS MACHINE CALIBRATED TO USE AN 84 G/L BICARBONATE CONCENTRATE WITH A DILUTION RATIO OF 1:27.6; IT MUST BE USED IN CONJUNCTION WITH FRESENIUS
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: TYPE 1:34 ACID HEMODIALYSIS CONCENTRATE; 3.78 L (1 GAL); 4 BOTTLES PER CASE
Related Searches:
ACULAR
KETOROLAC TROMETHAM
NSN, MFG P/N
6505013850495
NSN
6505-01-385-0495
MFG
ALLERGAN INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 0.5% KETOROLAC TROMETHAMINE; 5 ML BT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION 5ML BT
Related Searches:
ACULAR 0.5 OPHTHALMIC SOLUTION
KETOROLAC TROMETHAM
NSN, MFG P/N
6505013850495
NSN
6505-01-385-0495
ACULAR 0.5 OPHTHALMIC SOLUTION
KETOROLAC TROMETHAM
NSN, MFG P/N
6505013850495
NSN
6505-01-385-0495
MFG
ALLERGAN INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 0.5% KETOROLAC TROMETHAMINE; 5 ML BT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION 5ML BT
Related Searches:
NDC00023-2181-05
KETOROLAC TROMETHAM
NSN, MFG P/N
6505013850495
NSN
6505-01-385-0495
MFG
ALLERGAN INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 0.5% KETOROLAC TROMETHAMINE; 5 ML BT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION 5ML BT
Related Searches:
GAVISCON
ALUMINA AND MAGNESI
NSN, MFG P/N
6505013850518
NSN
6505-01-385-0518
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 508 MG PER 10 ML ALUMINUM HYDROXIDE; 475 MG PER 10 ML MAGNESIUM CARBONATE; 12 FLUID OUNCES PER BOTTLE; 12 BOTTLES PER PG
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALUMINA AND MAGNESIUM CARBONATE ORAL SUSPENSION USP 12OZ BT 12S
Related Searches:
GAVISCON EXTRA STRENGTH LIQUID
ALUMINA AND MAGNESI
NSN, MFG P/N
6505013850518
NSN
6505-01-385-0518
GAVISCON EXTRA STRENGTH LIQUID
ALUMINA AND MAGNESI
NSN, MFG P/N
6505013850518
NSN
6505-01-385-0518
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 508 MG PER 10 ML ALUMINUM HYDROXIDE; 475 MG PER 10 ML MAGNESIUM CARBONATE; 12 FLUID OUNCES PER BOTTLE; 12 BOTTLES PER PG
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALUMINA AND MAGNESIUM CARBONATE ORAL SUSPENSION USP 12OZ BT 12S
Related Searches:
NDC00088-1173-12
ALUMINA AND MAGNESI
NSN, MFG P/N
6505013850518
NSN
6505-01-385-0518
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 508 MG PER 10 ML ALUMINUM HYDROXIDE; 475 MG PER 10 ML MAGNESIUM CARBONATE; 12 FLUID OUNCES PER BOTTLE; 12 BOTTLES PER PG
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALUMINA AND MAGNESIUM CARBONATE ORAL SUSPENSION USP 12OZ BT 12S
Related Searches:
NDC00019-1333-06
IOVERSOL INJECTION
NSN, MFG P/N
6505013850787
NSN
6505-01-385-0787
MFG
MALLINCKRODT DIAGNOSTICS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 74.000 PERCENTAGE W/V IVEROSOL
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PROVIDES 35% (350 MG/ML) ORGANICALLY BOUND IODINE
